se of antiviral drugs in breast cancer
Not Applicable
- Conditions
- Health Condition 1: C50- Malignant neoplasm of breast
- Registration Number
- CTRI/2019/08/020604
- Lead Sponsor
- Dr T M A Pai Fellowship
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed female breast cancer patients.
Patients scheduled for Modified Radical Mastectomy (MRM) or Breast Conservative Surgery (BCS).
Patients who are willing to give informed consent.
Exclusion Criteria
Vulnerable patients
HIV, TB, Hepatitis positive patients.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method KDM5B Gene Expression in Indian Breast cancer patientsTimepoint: 2 years
- Secondary Outcome Measures
Name Time Method In vitro and In vivo analysis of selected drug molecules targeting KDM5B oncogeneTimepoint: 3 years